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With the advent of the new era of immune therapy, new
aspects of inﬂammation as a process involved in therapy, in
tumorigenesis, and in several other human pathologies have
been highlighted [1]. This special issue attempted to cover
as many of these inﬂammation aspects in original papers
and in extended reviews.
It is possible to trait two distinct sections discussing
inﬂammation aspects; a series of papers focusing on oncology
and a series of papers focusing on other inﬂammation-related
pathologies. From the ﬁrst series of papers, M. Tampa et al.
review the inﬂammatory markers of oral squamous cell carci-
noma highlighting the main markers of inﬂammation that
could improve early diagnosis. In esophageal squamous cell
carcinoma cells, M. Wang et al. show that in in vitro studies,
PAR4 can have a tumor suppressor role and can be used as a
future therapeutic target. In endometrial cancer, S. Gu et al.
show that tumor-associated macrophages are predominantly
type 2 (M2) that contribute to the progression of this type of
cancer and that the anti-CD27 therapy could have an antitu-
moral eﬀect. Similarly, tumor-associated macrophages are
reviewed by H. Degroote et al. in another type of cancer,
hepatocellular carcinoma. The preclinical evolution and
hitherto clinical trials for TAM-targeted therapy in HCC
have been highlighted.
A syndrome associated with cancer progression is
cachexia, reviewed by E. Manole et al. The paper is describing
several myokines produced and released bymyocytes that can
become potential biomarkers and future therapeutic targets.
As already mentioned, immune therapy would be proba-
bly one of the major breakthroughs in oncology. C. Vajaitu
et al. review checkpoint inhibitor new treatments and the role
of inﬂammation in these therapies presenting biomarkers
that could predict eﬃcacy and immune therapy resistance.
A. Calinescu et al. reviewed an inﬂammatory-related
protein, carcinoembryonic antigen-related cell adhesion
molecule 1, and its involvement in malignancies. The paper
shows its importance as a prognostic factor in oncology and
a future target speciﬁc cancer therapy.
The second section of the special issue consists of reviews
and original papers evaluating inﬂammation in various
nononcological diseases. A. Pedrinolla et al. evaluate proin-
ﬂammatory markers of age-related obesity. M. Bucur et al.
highlight in their original paper that there are clear proﬁbro-
tic and antiﬁbrotic factors expression diﬀerences in oral
mucosa and skin scars.
M. Dobre et al. show that diﬀerences found in various
transcript levels of inﬂammatory molecules could aid the
diﬀerential diagnosis between ulcerative colitis and Crohn’s
disease. Chronic kidney disease could beneﬁt from current
proteomic approaches, as S. Mihai et al. are describing the
inﬂammasomes and gut microbiota dysbiosis involvement
in this disease and moreover in the renal malignancy.
An in vivo animal model is shown by E. Codrici et al.
where a caveolin-1-knockout mouse is thoroughly charac-
terized and presented as a good inﬂammatory disease
model. Another original paper by V.M. Anghelescu et al.
shows the inﬂammatory pattern evaluation in animal models
associated with various bone implants. Last, but not least,
S.R. Georgescu et al. revise the traits of chronic inﬂammation
in HPV infection that can lead to tumorigenesis.
Hindawi
Journal of Immunology Research
Volume 2019, Article ID 5403910, 2 pages
https://doi.org/10.1155/2019/5403910
We are very satisﬁed that our subject resulted in so many
valuable papers, and we would like to thank all the authors
who submitted their work for consideration to this special
issue. Without their eﬀort, this special issue would have not
taken place. Editors would like to thank the reviewers who
thoroughly revised the papers and provided important
suggestions that signiﬁcantly improved the papers.
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